Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sertraline Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1390198A reveals a novel ketimine preparation method eliminating TiCl4. Achieve high-purity sertraline intermediates with reduced ecological impact and cost.
Discover the patented protic solvent method for producing high-purity ketimines. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.